• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of postmedjPostgraduate Medical JournalCurrent TOCInstructions for authors
Postgrad Med J. Dec 1992; 68(806): 974–975.
PMCID: PMC2399491

Strongyloides stercoralis hyperinfection in a patient with angioimmunoblastic lymphadenopathy.

Abstract

A 29 year old Bengali male patient on chemotherapy for angioimmunoblastic lymphadenopathy developed Strongyloides hyperinfection syndrome 3 months after being treated with a single 3 day course of thiabendazole. His complicated hospitalization and successful management are described. Prevention of this potentially fatal disease in immunocompromised patients by early diagnosis and proper management of intestinal strongyloidiasis is emphasized.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (256K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med. 1966 Nov 17;275(20):1093–1096. [PubMed]
  • Steinberg AD, Seldin MF, Jaffe ES, Smith HR, Klinman DM, Krieg AM, Cossman J. NIH conference. Angioimmunoblastic lymphadenopathy with dysproteinemia. Ann Intern Med. 1988 Apr;108(4):575–584. [PubMed]
  • Knecht H. Angioimmunoblastic lymphadenopathy: ten years' experience and state of current knowledge. Semin Hematol. 1989 Jul;26(3):208–215. [PubMed]
  • DeVault GA, Jr, King JW, Rohr MS, Landreneau MD, Brown ST, 3rd, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990 Jul-Aug;12(4):653–671. [PubMed]
  • Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis. 1981 May-Jun;3(3):397–407. [PubMed]
  • Grove DI. Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Trans R Soc Trop Med Hyg. 1982;76(1):114–118. [PubMed]
  • Naquira C, Jimenez G, Guerra JG, Bernal R, Nalin DR, Neu D, Aziz M. Ivermectin for human strongyloidiasis and other intestinal helminths. Am J Trop Med Hyg. 1989 Mar;40(3):304–309. [PubMed]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...